Indonesia is fighting one of the worst coronavirus outbreaks in Asia. On January 13, 2021, the country started one of the world’s biggest COVID-19 vaccination drives. The plan is to inoculate 181.5 million people – two third of the population – in 15 months using primarily the CoronaVac from China’s Sinovac Biotech. The vaccination campaign is ambitious and its success hinges on a number of supply and demand side factors which are subject to investigation in this project.
DFG, 2021-2022

Head

Prof. Dr. Renate Hartwig

Associate

Dr. Jan Priebe

Former Associate

Research Questions

We aim to look at two aspects in particular:

1) On the demand-side, we aim to study in particular the role of religion for vaccine uptake.

2) On the supply-side, we aim to study discrimination in access to health care and vaccination.

Contribution to International Research

We aim at providing rigorous evidence on the role of religious beliefs for access to and demand of health services in the context of Indonesia. Beyond our scientific contribution, the findings are also of high policy relevance, not only in Indonesia but also for countries with substantial Muslim population shares and countries where discrimination in the access to health services is still endemic.

Research Design and Methods

This study combines a standarized patient design with extensive survey evidence.

GIGA Focus Global | 3/2022

COVID-19 and Violent Actors in the Global South: A Complex Relationship

A cross-regional comparative analysis of the effects of COVID-19 on violence shows high levels of variation between contexts and in terms of specific armed actors. While Latin America along with the Middle East and North Africa have experienced an overall reduction, violence in sub-Saharan Africa has increased.

Yannick Deepen

Dr. André Bank

Dr. Julia Grauvogel

Prof. Dr. Sabine Kurtenbach

Home
Research & Transfer
Research Projects
Investigating Supply & Demand Side Factors of a Massive Covid-19 Vaccination Drive: Experimental Evidence from Indonesia